ULTA.NASDAQUlta Beauty, INC

Form 4: Ulta Beauty Executive Receives Stock Grant, Options

Sentiment:

Statement of Changes in Beneficial Ownership


Ulta Beauty's SVP, Controller, Christopher Lialios, was granted restricted stock and stock options as part of his compensation.

Summary

  • Christopher Lialios, SVP, Controller (P. Acct Ofc.) of Ulta Beauty, Inc., reported a transaction on March 31, 2026.
  • He received a grant of 519 shares of restricted stock, which will vest fully on March 15, 2029.
  • Additionally, Lialios was granted stock options to purchase 757 shares of common stock, with an exercise price of $522.71.
  • These options will vest in 25% increments annually starting March 15, 2027, through March 15, 2030.
  • Following these transactions, Lialios beneficially owns 3,550 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it details routine executive compensation transactions rather than significant financial performance or strategic shifts.

Positives

  • Grant of restricted stock indicates a long-term incentive for the executive.
  • Stock options provide potential upside for the executive tied to the company's stock performance.
  • The executive's direct beneficial ownership of 3,550 shares suggests alignment with shareholder interests.

Risks

  • The exercise price of the stock options ($522.71) is significantly higher than the current market price, implying that the options may not be in-the-money.
  • Vesting schedules for both restricted stock and options mean that the executive's full benefit is contingent on continued employment and future company performance.

Future Outlook

The future outlook for the executive's compensation is tied to the vesting schedules of the granted restricted stock and stock options, which extend through March 2030. The value realized will depend on Ulta Beauty's stock performance.

Industry Context

StockSavvy.ai notes that the granting of restricted stock and stock options is a common practice in the retail industry for executive compensation, designed to align management's interests with those of shareholders and incentivize long-term performance.

Stakeholder Impact

  • Shareholders: The grants are part of executive compensation, which impacts the company's expense structure. The alignment of executive incentives with stock performance can be viewed positively.
  • Employees: This filing does not directly impact general employees but reflects the compensation structure for senior leadership.
  • Management: The executive benefits from these grants, contingent on continued service and company performance.

Next Steps

  • Christopher Lialios will continue to vest in his restricted stock and stock options according to the outlined schedules.
  • Ulta Beauty, Inc. will continue to report executive compensation transactions as they occur.

Key Dates

DateDescription
03/15/2027First vesting date for 25% of stock options.
03/15/2029Full vesting date for restricted stock grant.
03/15/2030Final vesting date for stock options.
03/31/2026Transaction date for stock grant and option grant.
04/02/2026Date the Form 4 was signed.

Keywords

Form 4, SEC Filing, Ulta Beauty, ULTA, Stock Options, Restricted Stock, Executive Compensation, Beneficial Ownership, Christopher Lialios

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.